Sally Barrington
Sally Barrington
Email verificata su kcl.ac.uk - Home page
Titolo
Citata da
Citata da
Anno
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification
BD Cheson, RI Fisher, SF Barrington, F Cavalli, LH Schwartz, E Zucca, ...
Journal of clinical oncology 32 (27), 3059, 2014
25732014
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
R Boellaard, R Delgado-Bolton, WJG Oyen, F Giammarile, K Tatsch, ...
European journal of nuclear medicine and molecular imaging 42 (2), 328-354, 2015
15072015
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...
Journal of clinical oncology 32 (27), 3048, 2014
10862014
Imaging biomarker roadmap for cancer studies
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169, 2017
5492017
Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma
J Radford, T Illidge, N Counsell, B Hancock, R Pettengell, P Johnson, ...
New England Journal of Medicine 372 (17), 1598-1607, 2015
5282015
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma
P Johnson, M Federico, A Kirkwood, A Foss, L Berkahn, A Carella, ...
N Engl J Med 374, 2419-2429, 2016
4882016
Detection of lymphoma in bone marrow by whole-body positron emission tomography
R Carr, SF Barrington, B Madan, MJ O'Doherty, CAB Saunders, ...
Blood, The Journal of the American Society of Hematology 91 (9), 3340-3346, 1998
3751998
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
SF Barrington, W Qian, EJ Somer, A Franceschetto, B Bagni, E Brun, ...
European journal of nuclear medicine and molecular imaging 37 (10), 1824-1833, 2010
3062010
International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers
A Biggi, A Gallamini, S Chauvie, M Hutchings, L Kostakoglu, M Gregianin, ...
Journal of Nuclear Medicine 54 (5), 683-690, 2013
2762013
PET scanning and the human immunodeficiency virus-positive patient
M O'Doherty, SF Barrington, M Campbell, J Lowe, CS Bradbeer
Journal of Nuclear Medicine 38 (10), 1575-1583, 1997
2501997
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
BD Cheson, S Ansell, L Schwartz, LI Gordon, R Advani, HA Jacene, ...
Blood 128 (21), 2489-2496, 2016
2492016
PET/CT for therapy response assessment in lymphoma
M Hutchings, SF Barrington
Journal of nuclear medicine 50 (Suppl 1), 21S-30S, 2009
2342009
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ...
Haematologica 99 (6), 1107, 2014
2302014
Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam
SF Barrington, MN Maisey
Journal of Nuclear Medicine 37 (7), 1127-1129, 1996
2221996
Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography
G Morton, A Chiribiri, M Ishida, ST Hussain, A Schuster, A Indermuehle, ...
Journal of the American College of Cardiology 60 (16), 1546-1555, 2012
2122012
PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement
AB Khan, SF Barrington, NG Mikhaeel, AA Hunt, L Cameron, T Morris, ...
Blood 122 (1), 61-67, 2013
2002013
Guidelines for 18 F-FDG PET and PET-CT imaging in paediatric oncology
J Stauss, C Franzius, T Pfluger, KU Juergens, L Biassoni, J Begent, ...
European journal of nuclear medicine and molecular imaging 35 (8), 1581-1588, 2008
1702008
Early chemotherapy intensification with BEACOPP in advanced‐stage Hodgkin lymphoma patients with a interim‐PET positive after two ABVD courses
A Gallamini, C Patti, S Viviani, A Rossi, F Fiore, F Di Raimondo, ...
British journal of haematology 152 (5), 551-560, 2011
1562011
Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG
GJR Cook, S Houston, SF Barrington, I Fogelman
Journal of Nuclear Medicine 39 (1), 99-103, 1998
1551998
Limitations of PET for imaging lymphoma
SF Barrington, MJ O'doherty
European Journal of Nuclear Medicine and Molecular Imaging 30 (1), S117-S127, 2003
1512003
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20